Hepatitis B Vaccine (Recombinant)

FDA Drug Profile — RECOMBIVAX HB, ENGERIX-B

Hepatitis B Vaccine (Recombinant) is listed in the FDA National Drug Code directory with 18 NDC codes, marketed under brand names including RECOMBIVAX HB, ENGERIX-B. Available dosage form: injection, suspension.

Drug details

Generic Name
Hepatitis B Vaccine (Recombinant)
Brand Names
RECOMBIVAX HB, ENGERIX-B
Application Number
BLA101066
Sponsor
Merck Sharp & Dohme LLC
NDC Codes
18
Dosage Forms
INJECTION, SUSPENSION
Routes
INTRAMUSCULAR, SUBCUTANEOUS
Active Ingredients
HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN, HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.